VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Stock Comparison

DexCom, Inc. vs Hims & Hers Health, Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

DexCom, Inc.

DXCM · Nasdaq Global Select Market

Market cap (USD)$23.6B
Gross margin (TTM)60.1%
Operating margin (TTM)19.6%
Net margin (TTM)17.9%
SectorHealthcare
IndustryMedical - Devices
CountryUS
Data as of2026-04-24
Moat score
82/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into DexCom, Inc.'s moat claims, evidence, and risks.

View DXCM analysis

Hims & Hers Health, Inc.

HIMS · New York Stock Exchange

Market cap (USD)$6.2B
Gross margin (TTM)73.8%
Operating margin (TTM)4.5%
Net margin (TTM)5.5%
SectorHealthcare
IndustryMedical - Equipment & Services
CountryUS
Data as of2025-12-29
Moat score
51/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Hims & Hers Health, Inc.'s moat claims, evidence, and risks.

View HIMS analysis

Comparison highlights

  • Moat score gap: DexCom, Inc. leads (82 / 100 vs 51 / 100 for Hims & Hers Health, Inc.).
  • Segment focus: DexCom, Inc. has 1 segment (100% in Continuous glucose monitoring systems); Hims & Hers Health, Inc. has 2 segments (97.4% in Online Platform).
  • Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
  • Moat breadth: DexCom, Inc. has 5 moat types across 3 domains; Hims & Hers Health, Inc. has 3 across 2.

Primary market context

DexCom, Inc.

Continuous glucose monitoring systems

Market

Global continuous glucose monitoring systems and glucose biosensing devices

Geography

Global, with FY2025 revenue 71.5% United States and 28.5% international

Customer

People with diabetes, metabolic-health users, caregivers, clinicians, payors, distributors and pharmacy channels

Role

CGM device manufacturer, disposable sensor supplier, software/data platform and distribution partner

Revenue share

100%

Hims & Hers Health, Inc.

Online Platform

Market

Direct-to-consumer telehealth + subscription pharmacy (cash-pay) for lifestyle and chronic conditions

Geography

Primarily United States

Customer

Consumers (end-users), paid out-of-pocket; supported by affiliated provider networks and pharmacy fulfillment

Role

D2C digital health platform + fulfillment (mail-order pharmacy and partners)

Revenue share

97.4%

Side-by-side metrics

DexCom, Inc.
Hims & Hers Health, Inc.
Ticker / Exchange
DXCM - Nasdaq Global Select Market
HIMS - New York Stock Exchange
Market cap (USD)
$23.6B
$6.2B
Gross margin (TTM)
60.1%
73.8%
Operating margin (TTM)
19.6%
4.5%
Net margin (TTM)
17.9%
5.5%
Sector
Healthcare
Healthcare
Industry
Medical - Devices
Medical - Equipment & Services
HQ country
US
US
Primary segment
Continuous glucose monitoring systems
Online Platform
Market structure
Oligopoly
Competitive
Market share
35.1% (estimated)
n/a
HHI estimate
4,452
n/a
Pricing power
Moderate
Moderate
Moat score
82 / 100
51 / 100
Moat domains
Demand, Network, Legal
Demand, Supply
Last update
2026-04-24
2025-12-29

Moat coverage

Shared moat types

Brand Trust

DexCom, Inc. strengths

Installed Base ConsumablesEcosystem ComplementsRegulated Standards PipeData Workflow Lockin

Hims & Hers Health, Inc. strengths

Habit DefaultOperational Excellence

Segment mix

DexCom, Inc. segments

Full profile >

Continuous glucose monitoring systems

Oligopoly

100%

Hims & Hers Health, Inc. segments

Full profile >

Online Platform

Competitive

97.4%

Wholesale

Competitive

2.6%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.